Newbridge Financial Services Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$834K Sell
7,607
-108
-1% -$15.4K 0.14% 121
2025
Q4
$1.28M Buy
7,715
+985
+15% +$165K 0.2% 90
2025
Q3
$1.32M Hold
6,730
0.2% 94
2025
Q2
$609K Sell
6,730
-100
-1% -$7.9K 0.1% 158
2025
Q1
$408K Buy
6,830
+630
+10% +$58.3K 0.1% 132
2024
Q4
$821K Sell
6,200
-155
-2% -$14.5K 0.21% 84
2024
Q3
$333K Buy
6,355
+3,350
+111% +$157K 0.12% 117
2024
Q2
$182K Buy
3,005
+2,980
+11,920% +$207K 0.07% 197
2024
Q1
$1.85K Buy
+25
New +$1.85K ﹤0.01% 999

Other funds holding ALAB

Newbridge Financial Services Group's ALAB Position: Q1 2026 in Review

Newbridge Financial Services Group reduced its Astera Labs (ALAB) stake by 1.4% in Q1 2026, selling an estimated $15.4K and leaving 7,607 shares worth $834K. The position accounts for 0.14% of the portfolio, ranked #121.

Newbridge Financial Services Group first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.32M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Newbridge Financial Services Group held 7,607 shares of Astera Labs worth $834K as of Q1 2026.
  • Newbridge Financial Services Group sold 108 Astera Labs shares in Q1 2026, an estimated $15.4K.
  • Astera Labs made up 0.14% of Newbridge Financial Services Group's portfolio in Q1 2026, its #121 holding.
  • Newbridge Financial Services Group first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Newbridge Financial Services Group's Astera Labs position peaked at $1.32M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.